A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatment

Journal of Infection

Volumn 36, Issue 3, 1998, Pages 259-267

  Korting, H C ^a   Patzak, U ^a   Schaller, M ^a   Maibach, H I ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ECONAZOLE; KERATIN; LIPOSOME;

ARTICLE; BIOLOGICAL MODEL; CANDIDA ALBICANS; CANDIDIASIS; DYSKERATOSIS; ELECTRON MICROSCOPY; EPIDERMIS; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; MICROSCOPY; PARAKERATOSIS; PATHOGENESIS; SKIN INFECTION; STRATUM CORNEUM; WOUND HEALING;

EID: 0031813119     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)94063-4     Document Type: Article

References (29)

1. Odds FC. Candida and Candidosis, second edition. London: Baillière Tindall, 1988.
2. Maibach HJ, Kligman AM. The biology of experimental human cutaneous moniliasis (Candida albicans). Arch Dermatol 1962; 85: 233-257.
3. Rebora A, Marples RR, Kligman AM. Experimental infection with Candida albicans. Arch Dermatol 1973; 108: 69-73.
4. Ray TL, Wuepper KD. Experimental cutaneous candidiasis in rodents. II. Role of the stratum corneum barrier and serum complement as a mediator of a protective inflammatory response. Arch Dermatol 1978: 114: 539-543.
5. Wildfeuer A. Experimental evaluation of the action of antimycotics against yeast-type fungi, using rabbit cutaneous candidiasis as a new criterion. Mykosen 1972; 15: 119-128.
6. Scherwitz C. Ultrastructure of human cutaneous candidiasis. J Invest Dermatol 1982; 78: 200-205.
7. Sohnle PG, Frank MM, Kirkpatrick CH. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. J Immunol 1976; 117: 523-530.
8. Van Cutsem J, Thienpont D. Experimental cutaneous Candida albicans infection in guinea pigs. J Med Vet Mycol (Sabouraudia) 1971; 9: 17.
9. Ray TL, Wuepper KD. Experimental cutaneous candidiasis in rodents. J Invest Dermatol 1976; 66: 29-33.
10. Sohnle PG, Kirkpatrick CH. Epidermal proliferation in the defense against experimental cutaneous candidiasis. J Invest Dermatol 1978; 70: 130-133.
11. Miyachi Y, Horio T, Imomura S. The fate of experimental cutaneous candidiasis in guinea pigs under suppressed polymorphonuclear leucocyte chemotaxis by colchicine. Arch Dermatol Res 1981; 271: 373-380.
12. Ollert MW, Soehnchen R, Korting HC et al. Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect Immun 1993; 61: 4560-4568.
13. Van Cutsem J, Thienpont D. Miconazole: a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy 1972; 17: 392-404.
14. Veronese M, Barzaghi D, Bertoncini A. Antifungal activity of fenticonazole in experimental dermatomycoses and candidiasis. Arzneim Forsch 1981; 31: 2137-2139.
15. Wildfeuer A. Influence of neomycin and hydrocortisone on the experimental cutaneous candidiasis in rabbits. Mykosen 1972; 15: 193-197.
16. Wildfeuer A. The treatment of cutaneous candidiasis in rabbits. J Med Vet Mycol (Sabouraudia) 1973; 11: 4-9.
17. Fartasch M, Ponec M. Improved barrier structure formation in air exposed human keratinocyte culture systems. J Invest Dermatol 1994; 102: 366-374.
18. Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol 1965; 27: 137-138.
19. Dalton AJ. A chrome-osmium fixative for electron microscopy. Anat Rec 1955; 121: 281.
20. Regnier M, Asselineau D, Lenoir MC. Human epidermis reconstructed on dermal substrates in vitro: an alternative to animals in skin pharmacology. Skin Pharmacol 1990; 3: 70-85.
21. Regnier M, Caron D, Reichert U et al. Reconstructed human epidermis: a model to study in vitro the barrier function of the skin. Skin Pharmacol 1992; 3: 49-56.
22. Cannon CL, Neal PJ, Kubilus J et al. Lipid, ultrastructure and barrier function; characterization of a new in vitro epidermal model. J Invest Dermatol 1994; 102: 600.
23. Kennedy MJ. Adhesion and association mechanisms of Candida albicans. In: McGinnis MR, ed. Current topics in medical mycology, vol. 2. New York: Springer Verlag, 1988: 73-169.
24. Negi M, Tsuboi R, Matsui T et al. Isolation and characterization of proteinase from Candida albicans. J Invest Dermatol 1984; 83: 32-36.
25. Ray TL, Payne CD, Morrow BJ. Candida albicans acid proteinase: characterization and role in candidiasis. In: Dunn BW, ed. Structure and function of the aspartic proteinases. New York: Plenum Press, 1991: 173-183.
26. Orfanos CE. Feinstrukturelle Morphologie und Histopathologie der verhornenden Epidermis. Stuttgart: Thieme Verlag, 1972.
27. Herzinger T, Korting HC, Maibach HI. Assessment of cutaneous and ocular irritancy: a decade of research on alternatives to animal experimentation. Fundam Appl Toxicol 1995; 24: 29-41.
28. Baadsgaard O. Immunologic mechanism of contact dermatitis. In: Menné T, Maibach HI, eds. Exogenous Dermatoses: Environmental Dermatitis. Boca Raton, Ann Arbor, Boston: CRC Press, 1991: 4-15.
29. Preusser HJ. Effects of in vitro treatment with econazole on the ultrastructure of Candida albicans. Mykosen 1976; 19: 304-316.